Works matching DE "DOCETAXEL"

Results: 3426
    1

    Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: EuroGemDoce group results.

    Published in:
    BJU International, 2025, v. 135, n. 6, p. 969, doi. 10.1111/bju.16645
    By:
    • Scilipoti, Pietro;
    • Longoni, Mattia;
    • de Angelis, Mario;
    • Zaurito, Paolo;
    • Massiet, Albane;
    • Dutto, Daniele;
    • Soria, Francesco;
    • Álvarez‐Maestro, Mario;
    • Bazán, Alfredo Aguilera;
    • Pradere, Benjamin;
    • Klatte, Tobias;
    • Contieri, Roberto;
    • Hurle, Rodolfo;
    • Krajewski, Wojciech;
    • Subiela, José Daniel;
    • Pichler, Renate;
    • Szostek, Aleksandra;
    • Marcq, Gautier;
    • Elena, José Luis Rodríguez;
    • Aranda, Javier
    Publication type:
    Article
    2
    3
    4
    5

    Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 652, doi. 10.3390/ph18050652
    By:
    • Hetta, Helal F.;
    • Alqifari, Saleh F.;
    • Alshehri, Khaled;
    • Alhowiti, Amirah;
    • Alharbi, Saud S.;
    • Mirghani, Hyder;
    • Alrasheed, Tariq;
    • Mostafa, Mohamed E. A.;
    • Sheikh, Mohammed;
    • Elodemi, Mahmoud;
    • Alhumaid, Sultan A.;
    • Ramadan, Yasmin N.;
    • Abd Ellah, Noura H.;
    • Sayad, Reem
    Publication type:
    Article
    6

    Real-world data on the efficacy and toxicity of induction chemotherapy in locally advanced nasopharyngeal carcinoma in a non-endemic population.

    Published in:
    Ecancermedicalscience, 2025, v. 19, n. 1824-1915, p. 1, doi. 10.3332/ecancer.2025.1832
    By:
    • Hidalgo Filho, Cassio Murilo;
    • Berlingieri Polho, Gabriel;
    • Augusto Moreira, Otavio;
    • de Oliveira Andrade, Matheus;
    • Cruz Parrela, Vinicius;
    • Ricucci Shinkado, Yumi;
    • de Almeida Robatto, Amanda Acioli;
    • Lazar Neto, Felippe;
    • Freitas, Ana Julia;
    • Teixeira Souza, Aurelio;
    • de Castro Junior, Gilberto;
    • Perez Mak, Milena
    Publication type:
    Article
    7

    Value in Oncology.

    Published in:
    Oncology (08909091), 2014, v. 28, n. 7, p. 643
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study.

    Published in:
    International Journal of Clinical Oncology, 2013, v. 18, n. 1, p. 62, doi. 10.1007/s10147-011-0344-x
    By:
    • Shimabukuro, Tomoyuki;
    • Sakano, Shigeru;
    • Matsuda, Kenji;
    • Kamiryo, Yoriaki;
    • Yamamoto, Norio;
    • Kaneda, Yoshitaka;
    • Nasu, Takahito;
    • Baba, Yoshikazu;
    • Suga, Akinobu;
    • Yamamoto, Mitsutaka;
    • Aoki, Akihiko;
    • Takai, Kimio;
    • Yoshihiro, Satoru;
    • Konishi, Motohiko;
    • Imoto, Katsuhiko;
    • Matsuyama, Hideyasu
    Publication type:
    Article
    41
    42
    43
    44

    Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 204, doi. 10.1007/s10147-011-0275-6
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Maita, Shinya;
    • Obara, Takashi;
    • Numakura, Kazuyuki;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Habuchi, Tomonori
    Publication type:
    Article
    45
    46
    47
    48
    49
    50